Terfluranol
| Terfluranol | |
|---|---|
| Terfluranol.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Terfluranol is a synthetic pharmaceutical compound that has been studied for its potential therapeutic effects. It belongs to a class of compounds known as nonsteroidal anti-inflammatory drugs (NSAIDs), which are commonly used to reduce inflammation and alleviate pain.
Chemical Structure[edit]
Terfluranol is characterized by its unique chemical structure, which includes a fluorinated aromatic ring. This structure is responsible for its pharmacological properties and its interaction with biological targets in the body.
Pharmacology[edit]
Terfluranol exerts its effects primarily through the inhibition of cyclooxygenase (COX) enzymes, which play a key role in the synthesis of prostaglandins. Prostaglandins are lipid compounds that contribute to inflammation, pain, and fever. By inhibiting COX enzymes, Terfluranol reduces the production of prostaglandins, thereby alleviating these symptoms.
Mechanism of Action[edit]
The mechanism of action of Terfluranol involves the selective inhibition of COX-2, an enzyme that is upregulated during inflammatory processes. This selectivity helps to minimize gastrointestinal side effects commonly associated with non-selective NSAIDs that inhibit both COX-1 and COX-2.
Therapeutic Uses[edit]
Terfluranol has been investigated for its potential use in treating various inflammatory conditions, such as arthritis, musculoskeletal pain, and postoperative pain. Its efficacy in these conditions is attributed to its anti-inflammatory and analgesic properties.
Side Effects[edit]
Like other NSAIDs, Terfluranol may cause side effects, particularly with long-term use. Common side effects include gastrointestinal discomfort, such as nausea, dyspepsia, and gastric ulceration. It is important for patients to use Terfluranol under medical supervision to mitigate these risks.
Related Compounds[edit]
Terfluranol is related to other NSAIDs, such as ibuprofen, naproxen, and celecoxib. These compounds share similar mechanisms of action but differ in their chemical structures and pharmacokinetic profiles.
Research and Development[edit]
Research on Terfluranol is ongoing to better understand its pharmacological properties and potential therapeutic applications. Studies are also being conducted to explore its safety profile and to develop formulations that enhance its efficacy and reduce side effects.
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
